WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Therapeuticsmd earnings were $179.0k for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TXMD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $95.0k, down 115.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TXMD reported annual earnings of -$569.0k, with -73.9% growth.

TXMD past earnings growth

How has TXMD's earnings growth performed historically?

Company
N/A
Industry
18.64%
Market
83.8%
TXMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TXMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

TXMD earnings history

Current Revenue
$3.4M
Current Earnings
$179.0k
Current Profit Margin
5.3%

TXMD Return on Equity

Current Company
0.7%
Current Industry
12%
Current Market
13.5%
TXMD's Return on Equity (0.7%)... subscribe to Premium to read more.
High Return on Equity Performance

TXMD Return on Assets

Current Company
0.5%
Current Industry
5%
TXMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TXMD announces earnings.

TXMD Return on Capital Employed

Current Company
0.64%
Current Industry
11.3%
TXMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TXMD vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TXMD$1.63M$179.00k-99.96%$0.02
RMTI$24.00k-$5.40MN/A-$0.15
OPTHN/AN/AN/AN/A
AYTU-$27.26M-$34.06MN/A-$4.55
CPHI-$1.21M-$3.55MN/A-$0.54
View Top Pharmaceutical Stocks

Therapeuticsmd Earnings Reports & History FAQ

What were Therapeuticsmd's earnings last quarter?

On TXMD's earnings call on Invalid Date, Therapeuticsmd (NASDAQ: TXMD) reported Q1 2026 earnings per share (EPS) of $0.01, up 116.67% year over year. Total TXMD earnings for the quarter were $95.00 thousand. In the same quarter last year, Therapeuticsmd's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.

Is Therapeuticsmd profitable or losing money?

As of the last Therapeuticsmd earnings report, Therapeuticsmd is currently profitable. Therapeuticsmd's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $179.00 thousand, a 108.52% decrease year over year.

What was TXMD's earnings growth in the past year?

As of Therapeuticsmd's earnings date in Invalid Date, Therapeuticsmd's earnings has grown year over year. TXMD earnings in the past year totalled $179.00 thousand.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.